Search - tctmd.com

Displaying 241 - 260 of 326

Sort: Relevancy | Date

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

L.A. McKeown

August 05, 2015

News Daily News

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

L.A. McKeown

August 05, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

Centers With Higher Volume of Peripheral Endovascular Procedures Have Better Results

Todd Neale

July 02, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Conference News ACC 2015

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

L.A. McKeown

March 15, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

L.A. McKeown

December 21, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Advertisement

ABSORB Trials Pit BRS Against Second-Generation DES

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

Meta-analysis Confirms Safety of PCI without Surgical Backup

Centers With Higher Volume of Peripheral Endovascular Procedures Have Better Results

Method Chosen to Estimate Pre-PCI Kidney Function Matters

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

DES With Biodegradable Polymer Safe, Durable Through 5 Years

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content